Aktis Oncology, Inc. (AKTS)
NASDAQ·Healthcare·Biotechnology
$21.91
-0.72%
Mkt Cap $1.23B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
Implied Upside
+61.3%
Consensus $35.33 vs current $21.91
NASDAQ·Healthcare·Biotechnology
$21.91
-0.72%
Mkt Cap $1.23B
Buy
3
Hold
0
Sell
0
Price Target (4 analysts)
$35.33
Range $31.00 – $40.00
+61.3%
Consensus $35.33 vs current $21.91